Inoue, K.; Kinoshita, M.; Muranishi, K.; Ohara, J.; Sudo, K.; Kawaguchi, K.; Shimizu, M.; Naito, Y.; Moriyama, K.; Sawa, T.
Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa. Vaccines 2023, 11, 1088.
https://doi.org/10.3390/vaccines11061088
AMA Style
Inoue K, Kinoshita M, Muranishi K, Ohara J, Sudo K, Kawaguchi K, Shimizu M, Naito Y, Moriyama K, Sawa T.
Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa. Vaccines. 2023; 11(6):1088.
https://doi.org/10.3390/vaccines11061088
Chicago/Turabian Style
Inoue, Keita, Mao Kinoshita, Kentaro Muranishi, Junya Ohara, Kazuki Sudo, Ken Kawaguchi, Masaru Shimizu, Yoshifumi Naito, Kiyoshi Moriyama, and Teiji Sawa.
2023. "Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa" Vaccines 11, no. 6: 1088.
https://doi.org/10.3390/vaccines11061088
APA Style
Inoue, K., Kinoshita, M., Muranishi, K., Ohara, J., Sudo, K., Kawaguchi, K., Shimizu, M., Naito, Y., Moriyama, K., & Sawa, T.
(2023). Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa. Vaccines, 11(6), 1088.
https://doi.org/10.3390/vaccines11061088